Victory Capital Management
BEAM icon

Victory Capital Management’s Beam Therapeutics BEAM Stock Holding History

Victory Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
10,840
-20,259
-65% -$612K ﹤0.01% 2127
2026
Q1 		$741K Buy
31,099
+117
+0.4% +$3.25K ﹤0.01% 1943
2025
Q4 		$859K Buy
30,982
+106
+0.3% +$2.7K ﹤0.01% 1897
2025
Q3 		$749K Sell
30,876
-167
-0.5% -$3.32K ﹤0.01% 1962
2025
Q2 		$528K Buy
31,043
+20,431
+193% +$356K ﹤0.01% 2050
2025
Q1 		$207K Buy
10,612
+1,618
+18% +$42.4K ﹤0.01% 2213
2024
Q4 		$223K Sell
8,994
-99
-1% -$2.53K ﹤0.01% 2207
2024
Q3 		$223K Sell
9,093
-828
-8% -$21.4K ﹤0.01% 2201
2024
Q2 		$232K Buy
9,921
+973
+11% +$23.9K ﹤0.01% 2164
2024
Q1 		$296K Sell
8,948
-334
-4% -$10.4K ﹤0.01% 2123
2023
Q4 		$253K Buy
+9,282
New +$231K ﹤0.01% 2174
2023
Q3 		– Sell
-21,483
Closed -$686K – 2521
2023
Q2 		$686K Sell
21,483
-151
-0.7% -$4.9K ﹤0.01% 1847
2023
Q1 		$662K Buy
21,634
+1,677
+8% +$66.2K ﹤0.01% 1895
2022
Q4 		$781K Sell
19,957
-1,236
-6% -$55.4K ﹤0.01% 1847
2022
Q3 		$1.01M Sell
21,193
-384
-2% -$21.9K ﹤0.01% 1729
2022
Q2 		$835K Sell
21,577
-663,609
-97% -$26.4M ﹤0.01% 1826
2022
Q1 		$38.8M Buy
685,186
+107,516
+19% +$7.05M 0.04% 629
2021
Q4 		$46M Sell
577,670
-120,209
-17% -$10.3M 0.04% 590
2021
Q3 		$60.7M Buy
697,879
+163,750
+31% +$16.5M 0.06% 460
2021
Q2 		$68.7M Sell
534,129
-59,476
-10% -$4.74M 0.07% 420
2021
Q1 		$47.5M Buy
593,605
+515,886
+664% +$49.1M 0.05% 566
2020
Q4 		$6.34M Sell
77,719
-22,022
-22% -$1.08M 0.01% 1180
2020
Q3 		$2.46M Sell
99,741
-18,437
-16% -$457K ﹤0.01% 1385
2020
Q2 		$3.31M Sell
118,178
-146,693
-55% -$3.16M ﹤0.01% 1276
2020
Q1 		$4.77M Buy
+264,871
New +$5.76M 0.01% 1097

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Victory Capital Management's BEAM Position: Q2 2026 in Review

Victory Capital Management reduced its Beam Therapeutics (BEAM) stake by 65% in Q2 2026, selling an estimated $612K and leaving 10,840 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Victory Capital Management first reported a position in BEAM in Q1 2020 and has held it in 25 quarters since. The position peaked at $68.7M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Victory Capital Management held 10,840 shares of Beam Therapeutics worth $372K as of Q2 2026.
  • Victory Capital Management sold 20,259 Beam Therapeutics shares in Q2 2026, an estimated $612K.
  • Beam Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2127 holding.
  • Victory Capital Management first reported a position in Beam Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Victory Capital Management's Beam Therapeutics position peaked at $68.7M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.